We Guide
WeGuide - Mobile healthcare data collection made easy.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
* | N/A | Grant | |
| Total Funding | 000k | ||
Related Content
We Guide operates as a specialized digital health company, offering a software-as-a-service (SaaS) platform for patient engagement and data collection. The firm was established as a spin-off from Curve Tomorrow, a digital health agency with over a decade of experience, leveraging that expertise to create its core product. The founders of Curve Tomorrow, and by extension the minds behind We Guide, are Mohinder Grewal and Sanji Ganeshan. Grewal's background is in biomedical engineering and commerce, while Ganeshan has a foundation in software engineering and has been involved in health tech for many years. Their combined experience in both the medical and technological fields underpins the company's direction.
The company's primary offering is the WeGuide platform, a tool that enables healthcare organizations, pharmaceutical companies, and research institutions to build their own patient-facing applications. This platform is designed to support decentralized clinical trials, facilitate the collection of real-world evidence (RWE), improve therapy adherence, and function as a digital companion for medical devices or drugs. By providing a self-service solution, WeGuide allows clients to create customized digital health tools without needing extensive in-house development resources. The business model is centered on providing this platform to clients, likely through licensing or subscription fees, thereby generating revenue from organizations conducting clinical research or seeking to improve patient care pathways.
A notable application of the WeGuide technology was its use in a large-scale World Health Organization (WHO) decentralized trial for COVID-19, which involved over 7,000 health professionals across several countries, including the USA, UK, and Australia. This demonstrates the platform's capacity to handle complex, global research initiatives. The core benefit for its clients lies in enhancing the connection with patients, which in turn leads to better adherence to study protocols or treatment plans, higher quality data, and ultimately improved health outcomes.
Keywords: digital health, patient engagement, decentralized clinical trials, real-world evidence, therapy adherence, SaaS, health-tech, patient data collection, medical research, companion apps